Evaluation of the effects of intake of fungus-derived ingredients on immunity and physical conditio
- Conditions
- Healthy Japanese adult
- Registration Number
- JPRN-UMIN000049706
- Lead Sponsor
- Medical Corporation Hokubukai Utsukushigaoka Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
1) Subjects using medical products. 2) Subjects who under treatment or with history of erious diabetes, kidney damage, hepatopathy and heart disease, hyroid disease, adrenal disease and other metabolic diseases. 3) Subjects who have a history of gastrointestinal disease (excluding a history of cecum). 4) Subjects who routinely take supplements that enhance immune function (agaricus, cordyceps, ericaceus, reishi mushroom, sparassis crispa, fucoidan, propolis, and lactic acid bacteria that promote the effectiveness of immune dunction). 5) Subjects who have chronic diseases and regularly use medicines. 6) Subjects who may have allergic symptoms to test foods, and subjects who may have allergic symptoms to other foods and medicines. 7) Subjects who routinely take steroids that may affect test results. 8) Subjects donated 200mL of blood in the past month or more than 400mL within 3 months. 9) Subjects with serious anemia. 10) Subjects who have tested positive for infectious disease (Syphilis, hepatitis B). 11) Subjects who have a history of drug dependence or alcohol dependence, or those who have a history of current illness. 12) Subjects who with eating disorders. 13) Subjects who take an amount of alcohol over 60g/day. 14) Subjects with possible changes of life style during the clinical studies. 15) Subjects who intend to become pregnant or lactating. 16) Subjects who participated in other clinical studied in the past 3 month. 17) Subjects judged as unsuitable for the study by the investigator for other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dendritic cells activity
- Secondary Outcome Measures
Name Time Method s-IgA, IgA, NK cell activity, neutrophil phagocytosis, antibody titer, questionnaire, Conditioning questionnaire, Safety